Advertisement

The Scientist

» FDA

Most Recent

image: Inconsistent Evidence

Inconsistent Evidence

By | January 22, 2014

More than a third of US drug approvals are based on a single large clinical trial, while others require more in-depth study, according to a new report.

0 Comments

image: Recognizing Basic Science Contributions

Recognizing Basic Science Contributions

By , , and | January 1, 2014

A “basic bibliography” for new drugs would provide scientists with soft incentives and acknowledge the value of basic biomedical research.

4 Comments

image: Speaking of Science

Speaking of Science

By | January 1, 2014

January 2014's selection of notable quotes

0 Comments

image: Prove Antibacterials are Safe: FDA

Prove Antibacterials are Safe: FDA

By | December 17, 2013

The Food and Drug Administration is asking companies to produce evidence that their antimicrobial washes do no harm.  

1 Comment

image: Antibiotic Limits Planned for Farms

Antibiotic Limits Planned for Farms

By | December 11, 2013

The Food and Drug Administration lays out a plan so that farmers will no longer use antibiotics to fatten up animals.  

2 Comments

image: 23andMe Steps Back

23andMe Steps Back

By | December 6, 2013

The company announces that it will stop offering health interpretations of personal genetic data.

4 Comments

image: 23andMe Now Facing Lawsuit

23andMe Now Facing Lawsuit

By | December 4, 2013

Shortly after getting in trouble with the Food and Drug Administration, the personal genetic testing company is slapped with a class action lawsuit.

8 Comments

image: FDA Approves NGS Tests

FDA Approves NGS Tests

By | November 21, 2013

The agency has cleared marketing of four next-generation sequencing devices from Illumina.

0 Comments

image: A Hair-Raising Solution?

A Hair-Raising Solution?

By | September 1, 2013

In the long-fought battle against baldness, researchers are finally identifying molecular pathways that can be manipulated to generate new hair follicles.

0 Comments

image: FDA Considers Easing Controls on Diabetes Drug

FDA Considers Easing Controls on Diabetes Drug

By | June 11, 2013

A panel of advisors says that the agency should loosen restrictions on the sale of a diabetes drug with a spotty clinical safety record.  

0 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement
RayBiotech
RayBiotech

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Enzo Life Sciences
Enzo Life Sciences
Advertisement
NeuroScientistNews
NeuroScientistNews